Co-Diagnostics, Inc. (CODX) Q1 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Co-diagnostics, Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.656 Thank you for standing by. At this time, I would like to welcome everyone to the Co-Diagnostics 00:00:05.656 -- 00:00:10.761 Inc. First Quarter 2026 Earnings Webcast. All lines have 00:00:10.761 -- 00:00:13.844 been placed on mute to prevent any background noise. 00:00:13.844 -- 00:00:17.907 After the speaker's remarks, there will be a question and answer session. 00:00:17.907 -- 00:00:22.491 If you would like to ask a question during this time, simply press star followed by the 00:00:22.491 -- 00:00:27.076 number one on your telephone keypad. I would now like to turn the conference over to 00:00:27.076 -- 00:00:32.943 Andrew Benson, Head of Investor Relations The floor is yours. 00:00:33.887 -- 00:00:38.254 Good afternoon, everyone. Thank you all for participating in today's conference call. 00:00:38.254 -- 00:00:42.500 On the line today from CoDiagnostics, we have Dwight Egan, Chief Executive Officer, and 00:00:42.500 -- 00:00:47.607 Brian Brown, Chief Financial Officer. Earlier today, CoDiagnostics released financial 00:00:47.607 -- 00:00:51.670 results from the first quarter ended March 31, 2026. 00:00:51.913 -- 00:00:55.278 A copy of the press release is available on the company's website. 00:00:55.278 -- 00:00:59.083 We will begin with management's prepared remarks and then open up the call to analyst 00:00:59.083 -- 00:01:03.599 Q&A. Before we begin, we would like to inform listeners that certain statements made 00:01:03.599 -- 00:01:07.643 by CoDiagnostics during this call, which are not historical facts or forward-looking 00:01:07.643 -- 00:01:11.728 statements. In addition to diagnostic test developments and timing for commencement of 00:01:11.728 -- 00:01:16.913 clinical evaluations, this includes statements concerning t...